title: Hepatic encephalopathy associated with combined clozapine and divalproex sodium treatment.
authors.forename: W C
authors.initials: WC
authors.lastname: Wirshing
authors.forename: D
authors.initials: D
authors.lastname: Ames
authors.forename: S
authors.initials: S
authors.lastname: Bisheff
authors.forename: J M
authors.initials: JM
authors.lastname: Pierre
authors.forename: A
authors.initials: A
authors.lastname: Mendoza
authors.forename: A
authors.initials: A
authors.lastname: Sun
mesh_terms: D000328:Adult; D003024:Clozapine / Q000009:adverse effects* / Q000493:pharmacokinetics; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006501:Hepatic Encephalopathy / Q000139:chemically induced*; D006801:Humans; D012702:Serotonin Antagonists / Q000009:adverse effects* / Q000493:pharmacokinetics; D014635:Valproic Acid / Q000009:adverse effects* / Q000493:pharmacokinetics
chemical_list: D004791:Enzyme Inhibitors; D012702:Serotonin Antagonists; D014635:Valproic Acid; D003024:Clozapine